146 related articles for article (PubMed ID: 37656048)
1. Advancement in biomarker based effective diagnosis of neonatal sepsis.
Gopal N; Chauhan N; Jain U; Dass SK; Sharma HS; Chandra R
Artif Cells Nanomed Biotechnol; 2023 Dec; 51(1):476-490. PubMed ID: 37656048
[TBL] [Abstract][Full Text] [Related]
2. Molecular imprinting based electrochemical biosensor for identification of serum amyloid A (SAA), a neonatal sepsis biomarker.
Balayan S; Chauhan N; Chandra R; Jain U
Int J Biol Macromol; 2022 Jan; 195():589-597. PubMed ID: 34920065
[TBL] [Abstract][Full Text] [Related]
3. Recent advances in developing biosensing based platforms for neonatal sepsis.
Balayan S; Chauhan N; Chandra R; Kuchhal NK; Jain U
Biosens Bioelectron; 2020 Dec; 169():112552. PubMed ID: 32931992
[TBL] [Abstract][Full Text] [Related]
4. The combination of procalcitonin and C-reactive protein or presepsin alone improves the accuracy of diagnosis of neonatal sepsis: a meta-analysis and systematic review.
Ruan L; Chen GY; Liu Z; Zhao Y; Xu GY; Li SF; Li CN; Chen LS; Tao Z
Crit Care; 2018 Nov; 22(1):316. PubMed ID: 30463590
[TBL] [Abstract][Full Text] [Related]
5. Systematic review and meta-analysis of the diagnostic value of four biomarkers in detecting neonatal sepsis in low- and middle-income countries.
Rees CA; Lim J; Westbrook AL; El Helou R; Schmid A; Rubin-Smith J; Shreeve K; Rotman C; Govindapillai S; Dorney K; Niescierenko M
BMJ Paediatr Open; 2023 Jan; 7(1):. PubMed ID: 36649385
[TBL] [Abstract][Full Text] [Related]
6. Progranulin as a novel biomarker in diagnosis of early-onset neonatal sepsis.
Rao L; Song Z; Yu X; Tu Q; He Y; Luo Y; Yin Y; Chen D
Cytokine; 2020 Apr; 128():155000. PubMed ID: 31982701
[TBL] [Abstract][Full Text] [Related]
7. Diagnosis of neonatal sepsis: the past, present and future.
Celik IH; Hanna M; Canpolat FE; Mohan Pammi
Pediatr Res; 2022 Jan; 91(2):337-350. PubMed ID: 34728808
[TBL] [Abstract][Full Text] [Related]
8. Serum amyloid A - A prime candidate for identification of neonatal sepsis.
Bengnér J; Quttineh M; Gäddlin PO; Salomonsson K; Faresjö M
Clin Immunol; 2021 Aug; 229():108787. PubMed ID: 34175457
[TBL] [Abstract][Full Text] [Related]
9. Immunologic biomarkers for diagnostic of early-onset neonatal sepsis.
Memar MY; Alizadeh N; Varshochi M; Kafil HS
J Matern Fetal Neonatal Med; 2019 Jan; 32(1):143-153. PubMed ID: 28797204
[TBL] [Abstract][Full Text] [Related]
10. Biomarkers for the Diagnosis of Neonatal Sepsis.
Cantey JB; Lee JH
Clin Perinatol; 2021 Jun; 48(2):215-227. PubMed ID: 34030810
[TBL] [Abstract][Full Text] [Related]
11. Validity of biomarkers in screening for neonatal sepsis - A single center -hospital based study.
Rashwan NI; Hassan MH; Mohey El-Deen ZM; Ahmed AE
Pediatr Neonatol; 2019 Apr; 60(2):149-155. PubMed ID: 29895470
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of procalcitonin as a diagnostic marker in neonatal sepsis.
Pravin Charles MV; Kalaivani R; Venkatesh S; Kali A; Seetha KS
Indian J Pathol Microbiol; 2018; 61(1):81-84. PubMed ID: 29567889
[TBL] [Abstract][Full Text] [Related]
13. C-Reactive Protein, Procalcitonin, and White Blood Count to Rule Out Neonatal Early-onset Sepsis Within 36 Hours: A Secondary Analysis of the Neonatal Procalcitonin Intervention Study.
Stocker M; van Herk W; El Helou S; Dutta S; Schuerman FABA; van den Tooren-de Groot RK; Wieringa JW; Janota J; van der Meer-Kappelle LH; Moonen R; Sie SD; de Vries E; Donker AE; Zimmerman U; Schlapbach LJ; de Mol AC; Hoffman-Haringsma A; Roy M; Tomaske M; F Kornelisse R; van Gijsel J; Visser EG; Plötz FB; Heath P; Achten NB; Lehnick D; van Rossum AMC
Clin Infect Dis; 2021 Jul; 73(2):e383-e390. PubMed ID: 32881994
[TBL] [Abstract][Full Text] [Related]
14. Potential biomarkers for effective screening of neonatal sepsis infections: An overview.
Chauhan N; Tiwari S; Jain U
Microb Pathog; 2017 Jun; 107():234-242. PubMed ID: 28377234
[TBL] [Abstract][Full Text] [Related]
15. Comparison of serum amyloid A concentrations with those of C-reactive protein and procalcitonin in diagnosis and follow-up of neonatal sepsis in premature infants.
Cetinkaya M; Ozkan H; Köksal N; Celebi S; Hacimustafaoğlu M
J Perinatol; 2009 Mar; 29(3):225-31. PubMed ID: 19078972
[TBL] [Abstract][Full Text] [Related]
16. The cut-off levels of procalcitonin and C-reactive protein and the kinetics of mean platelet volume in preterm neonates with sepsis.
Aydemir C; Aydemir H; Kokturk F; Kulah C; Mungan AG
BMC Pediatr; 2018 Aug; 18(1):253. PubMed ID: 30068303
[TBL] [Abstract][Full Text] [Related]
17. Procalcitonin and Neonatal Sepsis: Is This the Biomarker We Are Looking For?
Bell SG
Neonatal Netw; 2017 Nov; 36(6):380-384. PubMed ID: 29185950
[TBL] [Abstract][Full Text] [Related]
18. Biomarkers for diagnosis of neonatal sepsis: a literature review.
Sharma D; Farahbakhsh N; Shastri S; Sharma P
J Matern Fetal Neonatal Med; 2018 Jun; 31(12):1646-1659. PubMed ID: 28427289
[TBL] [Abstract][Full Text] [Related]
19. Combination of Procalcitonin, CRP and CD11b Biomarkers in Early Detection of Neonatal Sepsis.
Fouad NA; Fouad MA; Assar EH; Eltaher SM
Egypt J Immunol; 2020 Jan; 27(1):77-86. PubMed ID: 33180390
[TBL] [Abstract][Full Text] [Related]
20. Biomarkers as point of care tests (POCT) in neonatal sepsis: A state of science review.
Taneja R; Batra P
J Neonatal Perinatal Med; 2021; 14(3):331-338. PubMed ID: 33337395
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
